5. Segment information
Operational segmentation
The group had two reportable segments, R&D and fee-for-service business. Due to the disposal of Fidelta d.o.o. (our fee-for-service segment), we reported this segment as discontinued operations. Galapagos is therefore operating as a single operating segment.
Geographical information
In 2020 our continuing operations were mainly located in Belgium, France and the Netherlands and our top 3 customers represented 99.9% of the revenues. Our client base in 2020 and 2019 included three of the largest pharmaceutical companies in the world.
Following table summarizes our revenues by destination of customer:
|
Year ended 31 December |
|
(thousands of €) |
2020 |
2019 |
United States of America |
472,445 |
793,873 |
Europe |
5,607 |
41,028 |
Total revenues |
478,053 |
834,901 |
Following table summarizes our revenues by major customers:
|
Year ended 31 December |
|||||
|
2020 |
2019 |
||||
|
(thousands of €) |
% |
(thousands of €) |
% |
||
Gilead |
|
|
|
|
||
United States of America(1) |
472,445 |
99% |
793,873 |
95% |
||
Europe(1) |
1,460 |
0% |
-4,570 |
-1% |
||
AbbVie |
|
|
|
|
||
Europe |
(52) |
0% |
26,356 |
3% |
||
Novartis |
|
|
|
|
||
Europe |
4,125 |
1% |
19,177 |
2% |
||
Total revenues from major customers |
477,978 |
100% |
834,836 |
100% |
||
|
On 31 December 2020, we held €171 million (€91 million in 2019) of property, plant and equipment and intangible assets distributed as follows:
|
31 December |
|||
(thousands of €) |
2020 |
2019(1) |
||
Belgium |
113,524 |
57,007 |
||
France |
18,398 |
18,102 |
||
The Netherlands |
28,210 |
7,951 |
||
Croatia |
- |
6,182 |
||
Switzerland |
7,668 |
1,057 |
||
Spain |
2,755 |
- |
||
Other |
388 |
681 |
||
Total |
170,943 |
90,979 |
||
|
As the net assets associated with Fidelta d.o.o. (Croatia) will be recovered principally through a sale transaction rather than through continuing use, we have classified these assets and the associated liabilities as held for sale in our financial statements for the year ended 31 December 2020.